Holdings of the Fund as of 3/18/2026
Total Number of Holdings (excluding cash): 50
| Merck & Co., Inc. |
MRK |
58933Y105 |
Pharmaceuticals |
20,535 |
$2,351,257.50 |
8.27% |
| Johnson & Johnson |
JNJ |
478160104 |
Pharmaceuticals |
9,751 |
$2,313,717.28 |
8.14% |
| Bristol-Myers Squibb Company |
BMY |
110122108 |
Pharmaceuticals |
36,614 |
$2,173,773.18 |
7.65% |
| Pfizer Inc. |
PFE |
717081103 |
Pharmaceuticals |
69,767 |
$1,906,034.44 |
6.71% |
| AbbVie Inc. |
ABBV |
00287Y109 |
Pharmaceuticals |
8,210 |
$1,710,471.40 |
6.02% |
| Cardinal Health, Inc. |
CAH |
14149Y108 |
Pharmaceuticals |
5,805 |
$1,229,905.35 |
4.33% |
| Biogen Inc. |
BIIB |
09062X103 |
Biotechnology |
6,413 |
$1,169,154.03 |
4.11% |
| Viatris Inc. |
VTRS |
92556V106 |
Pharmaceuticals |
81,869 |
$1,124,880.06 |
3.96% |
| Regeneron Pharmaceuticals, Inc. |
REGN |
75886F107 |
Biotechnology |
1,487 |
$1,106,506.44 |
3.89% |
| Eli Lilly and Company |
LLY |
532457108 |
Pharmaceuticals |
1,179 |
$1,082,380.95 |
3.81% |
| Gilead Sciences, Inc. |
GILD |
375558103 |
Pharmaceuticals |
7,631 |
$1,078,183.99 |
3.79% |
| Amgen Inc. |
AMGN |
031162100 |
Pharmaceuticals |
3,002 |
$1,055,142.96 |
3.71% |
| United Therapeutics Corporation |
UTHR |
91307C102 |
Pharmaceuticals |
1,934 |
$1,025,696.90 |
3.61% |
| Vertex Pharmaceuticals Incorporated |
VRTX |
92532F100 |
Pharmaceuticals |
2,206 |
$996,207.54 |
3.51% |
| Jazz Pharmaceuticals Plc |
JAZZ |
G50871105 |
Pharmaceuticals |
4,052 |
$731,183.40 |
2.57% |
| Zoetis Inc. |
ZTS |
98978V103 |
Pharmaceuticals |
5,510 |
$646,598.50 |
2.28% |
| Illumina, Inc. |
ILMN |
452327109 |
Biotechnology |
4,296 |
$528,193.20 |
1.86% |
| PTC Therapeutics, Inc. |
PTCT |
69366J200 |
Biotechnology |
6,157 |
$412,519.00 |
1.45% |
| Incyte Corporation |
INCY |
45337C102 |
Biotechnology |
4,358 |
$401,981.92 |
1.41% |
| Exelixis, Inc. |
EXEL |
30161Q104 |
Biotechnology |
8,587 |
$354,299.62 |
1.25% |
| Charles River Laboratories International, Inc. |
CRL |
159864107 |
Biotechnology |
2,112 |
$331,816.32 |
1.17% |
| Elanco Animal Health Incorporated |
ELAN |
28414H103 |
Pharmaceuticals |
13,348 |
$331,430.84 |
1.17% |
| Arrowhead Pharmaceuticals, Inc. |
ARWR |
04280A100 |
Biotechnology |
5,325 |
$301,980.75 |
1.06% |
| BioMarin Pharmaceutical Inc. |
BMRN |
09061G101 |
Pharmaceuticals |
5,035 |
$279,090.05 |
0.98% |
| Medpace Holdings, Inc. |
MEDP |
58506Q109 |
Biotechnology |
576 |
$261,964.80 |
0.92% |
| Halozyme Therapeutics, Inc. |
HALO |
40637H109 |
Biotechnology |
3,280 |
$208,772.00 |
0.73% |
| Alkermes Plc |
ALKS |
G01767105 |
Pharmaceuticals |
7,280 |
$198,016.00 |
0.70% |
| Amneal Pharmaceuticals, Inc. |
AMRX |
03168L105 |
Pharmaceuticals |
16,087 |
$199,317.93 |
0.70% |
| Krystal Biotech, Inc. |
KRYS |
501147102 |
Biotechnology |
796 |
$199,660.68 |
0.70% |
| Ionis Pharmaceuticals, Inc. |
IONS |
462222100 |
Pharmaceuticals |
2,753 |
$197,307.51 |
0.69% |
| Protagonist Therapeutics, Inc. |
PTGX |
74366E102 |
Biotechnology |
1,988 |
$193,014.92 |
0.68% |
| Neurocrine Biosciences, Inc. |
NBIX |
64125C109 |
Biotechnology |
1,342 |
$175,412.82 |
0.62% |
| BridgeBio Pharma, Inc. |
BBIO |
10806X102 |
Biotechnology |
2,265 |
$158,821.80 |
0.56% |
| Ligand Pharmaceuticals Inc. (Class B) |
LGND |
53220K504 |
Biotechnology |
727 |
$152,321.04 |
0.54% |
| Guardant Health, Inc. |
GH |
40131M109 |
Biotechnology |
1,738 |
$151,675.26 |
0.53% |
| Mirum Pharmaceuticals, Inc. |
MIRM |
604749101 |
Biotechnology |
1,586 |
$145,372.76 |
0.51% |
| NewAmsterdam Pharma Company N.V. |
NAMS |
N62509109 |
Biotechnology |
4,879 |
$143,637.76 |
0.51% |
| Catalyst Pharmaceuticals, Inc. |
CPRX |
14888U101 |
Biotechnology |
5,862 |
$133,712.22 |
0.47% |
| Supernus Pharmaceuticals, Inc. |
SUPN |
868459108 |
Pharmaceuticals |
2,601 |
$128,203.29 |
0.45% |
| Insmed Incorporated |
INSM |
457669307 |
Biotechnology |
864 |
$123,292.80 |
0.43% |
| Madrigal Pharmaceuticals, Inc. |
MDGL |
558868105 |
Biotechnology |
269 |
$118,898.00 |
0.42% |
| TG Therapeutics, Inc. |
TGTX |
88322Q108 |
Biotechnology |
3,999 |
$120,129.96 |
0.42% |
| Prestige Consumer Healthcare Inc. |
PBH |
74112D101 |
Pharmaceuticals |
1,835 |
$111,476.25 |
0.39% |
| ADMA Biologics, Inc. |
ADMA |
000899104 |
Biotechnology |
6,798 |
$101,086.26 |
0.36% |
| Rhythm Pharmaceuticals, Inc. |
RYTM |
76243J105 |
Biotechnology |
1,138 |
$97,708.68 |
0.34% |
| ACADIA Pharmaceuticals Inc. |
ACAD |
004225108 |
Biotechnology |
4,517 |
$91,785.44 |
0.32% |
| US Dollar |
$USD |
|
Other |
86,848 |
$86,848.04 |
0.31% |
| Alnylam Pharmaceuticals, Inc. |
ALNY |
02043Q107 |
Biotechnology |
260 |
$81,848.00 |
0.29% |
| Tempus AI, Inc. (Class A) |
TEM |
88023B103 |
Biotechnology |
1,547 |
$75,323.43 |
0.27% |
| Perrigo Company Plc |
PRGO |
G97822103 |
Pharmaceuticals |
6,406 |
$63,675.64 |
0.22% |
| Corcept Therapeutics Inc. |
CORT |
218352102 |
Pharmaceuticals |
1,683 |
$56,043.90 |
0.20% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|